Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-1.23%
SPX
-1.60%
IXIC
-2.24%
FTSE
-0.70%
N225
-0.66%
AXJO
-0.92%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Verve Therapeutics News

cnbc.com

Stocks making the biggest moves midday: Jabil, JetBlue, Sunrun, Valero, Verve Therapeutics and more

Feature Image for interests on Breaking News: Economy, Breaking News: Markets, Communication Services, Economy from cnbc.com
about 2 months ago
cnbc.com

Stocks making the biggest moves premarket: Sunrun, Verve Therapeutics, T-Mobile and more

Feature Image for interests on Breaking News: Economy, Breaking News: Markets, Communication Services, Consumer Cyclical from cnbc.com
about 2 months ago
benzinga.com

Eli Lilly Expands Into Gene Editing With Verve Therapeutics Acquisition

Feature Image for interests on Biotech, Briefs, Healthcare, Large Cap from benzinga.com
about 2 months ago
benzinga.com

CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: Analyst

Feature Image for interests on Analyst Color, Analyst Ratings, Benzinga, Biotech from benzinga.com
3 months ago
prnewswire.com

MosquitoMate receives first Vector Expedited Review Voucher (VERV) from the US Environmental Protection Agency

Feature Image for interests on Environmental Products & Services, Health Care & Hospitals, Infection Control, New Products & Services from prnewswire.com
8 months ago
finance.yahoo.com

Jim Cramer on Verve Therapeutics Inc. (VERV): ‘I Think It’s A Winner’

Feature Image for interests on Artificial Intelligence, ETF, Financial Services, Jim Cramer from finance.yahoo.com
11 months ago
businesswire.com

Shareholder Rights Attorneys Robbins LLP Reminds VERV Stockholders of the Opportunity to Lead the Verve Therapeutics, Inc. Class Action

Feature Image for interests on Stock, Unknown Sector from businesswire.com
11 months ago
businesswire.com

Shareholder Rights Attorneys Robbins LLP Reminds VERV Stockholders of the Opportunity to Lead the Verve Therapeutics, Inc. Class Action

Feature Image for interests on Stock, Unknown Sector from businesswire.com
11 months ago
finance.yahoo.com

Verve Therapeutics, Inc. (VERV): Among the Worst ARK Stocks According to Short Sellers

Feature Image for interests on Ark Investment, Artificial Intelligence, Buying Stocks, Cathie Wood from finance.yahoo.com
11 months ago
finance.yahoo.com

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Feature Image for interests on Cardiovascular Disease, Gene Editing, Genetic Medicines, Restricted Stock Units from finance.yahoo.com
11 months ago
Stocks
Health Care
verv
Verve Therapeutics
NASDAQ: VERV
0.00 (0.00%)
11.13
USD
At close at Aug 01, 20:45 UTC
Summary
News
Signals
Benchmarks
Financials

Latest Cashu News

publisher logo
Cashu

Verve Therapeutics: Embracing Innovative Mosquito Control for Public Health Solutions

8 months ago